FIG 4.

Racial and ethnic disparities in EOL opioid access by Medicaid dual-eligibility: (A) the adjusted absolute differences by race, ethnicity, and Medicaid dual-eligibility in the probability of filling any opioid near EOL; (B) in the probability of filling a long-acting opioid near EOL; (C) in opioid dose in MMED among patients filling an opioid prescription near EOL; and (D) in the total dose of opioids filled per decedent near EOL in MMEs. White dual-eligible patients are the reference group for all analyses. Circles reflect the adjusted correlation coefficients and the error bars reflect the 95% CIs from regression models. For all analyses, EOL was defined as the last 30 days before death or hospice. Bold text and asterisk indicates the presence of a statistically significant negative interaction between race, ethnicity, and Medicaid dual-eligibility. EOL, end of life; MME, morphine milligram equivalent; MMED, morphine milligram equivalent per day.